ABT-263

Chemical Information
Navitoclax is a N-sulfonylcarboxamide resulting from the formal condensation of the carboxy group of 4-{4-[(4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro[biphenyl]-2-yl)methyl]piperazin-1-yl}benzoic acid with the amino group of 4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide. It is a BH3-mimetic drug which targets the anti-apoptotic B-cell lymphoma-2 (BCL-2) family proteins, including BCL-2, BCL-xL, and BCL-w, and induces apoptosis in cancer cells. Currently under clinical investigation as treatment for solid tumors and hematologic malignancies. It has a role as a B-cell lymphoma 2 inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of piperazines, an aryl sulfide, a sulfone, an organofluorine compound, a member of morpholines, a secondary amino compound, a tertiary amino compound, a member of monochlorobenzenes and a N-sulfonylcarboxamide.
| CAS Number | 923564-51-6 |
| PubChem CID | 24978538 |
| IUPAC Name | 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide |
| Molecular Formula | C47H55ClF3N5O6S3 |
| Molecular Weight | 974.6 |
| XLogP | 9.6 |
| Topological Polar Surface Area | 170 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 16 |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1800 |
| Property | Value |
|---|---|
| Molecular Weight | 974.6 |
| XLogP3 | 9.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 16 |
| Exact Mass | 973.2955102 |
| Monoisotopic Mass | 973.2955102 |
| Topological Polar Surface Area | 170 Ų |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1800 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Related Products
Alternative Products
Popular Products

Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) PYL11 Polyclonal Antibody
SKU: MBS9006887|Size: Inquire

PYL11 Antibody
SKU: GTR17958256|Size: 2 mg

LK-2
SKU: ABC-TC0587|Size: 1 Vial

SequaGel MD Monomer Solution
SKU: EC-845|Size: 200 mL

West Nile Virus - Envelope protein
SKU: REC31614-100|Size: 1 Each

Yellow Fever Virus- NS1
SKU: YFV-NS1-100|Size: 1 Each

Dengue Virus Serotype 4 NS1 Protein (HEK293)
SKU: DENV4-NS1-100|Size: 1 Each

West Nile Virus -NS1
SKU: WNV-NS1-100|Size: 1 Each

Tick-Borne Encephalitis Virus NS1
SKU: TBEV-NS1-100|Size: 1 Each

Glucose M9Y
SKU: 0108|Size: 500 g

Canine Anti Granulocyte Colony Stimulating Factor Antibody
SKU: GTR10434816|Size: 96 Well

Canine anti-Bullous Pemphigoid 230 antibody
SKU: MBS7277633-01|Size: 48 Well

Canine Anti Granulocyte Colony Stimulating Factor Antibody
SKU: MBS7277656-01|Size: 48 Well

Anti-VP2 (Canine parvovirus)
SKU: IT-015-012EM1-01|Size: 0.1 mg

Anti-NT-proBNP, canine
SKU: GTR18245956-01|Size: 1 mg

Anti-NT-proBNP, canine
SKU: GTR18245959-01|Size: 1 mg

Anti-CRP, canine
SKU: GTR18245964-01|Size: 1 mg

Anti-CRP, canine
SKU: GTR18245965-01|Size: 1 mg

Izenivetmab Biosimilar - Anti-NGFB (Canine) mAb - Research Grade
SKU: PX-TA1854-01|Size: 50 µg

Cirevetmab Biosimilar - Anti-TGFB1 (Canine) mAb - Research Grade
SKU: PX-TA1826-01|Size: 50 µg
